Related Experiment Videos
[Data on repeated studies on the blood lipid levels in evaluating the severity of chronic ischemic heart disease]
Insights
Patients with coronary disease and lipid metabolism disorders, particularly hyperlipoproteinemia type II, often experience severe disease and unfavorable outcomes. Stable lipid levels correlate with milder coronary disease symptoms and slower progression.
Area of Science:
- Cardiology
- Lipid Metabolism
- Atherosclerosis Research
Context:
- Coronary artery disease (CAD) affects millions globally, with lipid metabolism disorders being a significant risk factor.
- Assessing the relationship between lipid profiles and CAD severity is crucial for patient management.
- Longitudinal studies tracking lipid levels and disease progression provide valuable insights.
Purpose:
- To investigate the correlation between lipid metabolism disorders and the severity and progression of coronary artery disease.
- To determine if specific types of hyperlipoproteinemia are associated with more severe CAD outcomes.
Summary:
- This 3-year study analyzed cholesterol, triglyceride, and lipoprotein levels in 125 coronary disease patients.
- Patients with stable normolipidemia exhibited milder symptoms and slower disease progression.
- Hyperlipoproteinemia, especially type II, was linked to severe CAD, extensive atherosclerosis, and unfavorable disease course.
Impact:
- Findings highlight the prognostic value of lipid metabolism assessment in coronary artery disease patients.
- Identifies hyperlipoproteinemia type II as a key indicator of severe and progressive atherosclerosis.
- Informs clinical practice regarding risk stratification and management strategies for CAD patients with lipid abnormalities.
Abstract:
During 3 years cholesterol, triglyceride and lipoprotein levels were repeatedly determined in the blood of 125 patients with coronary disease, and the severity of the disease was assessed with bicycle ergometry and coronarography. A relationship has been established between the severity of the disease and its course and the degree of disorders in the lipid metabolism. Group with stable normolipidemia (28%) showed less manifest symptoms of the disease and absence of rapid progression with new coronary accidents. Groups with hyperlipoproteinemia both stable (52.8%) and transient (19.2%) had predominantly severe forms of the disease running unfavourable course. The more frequent with severe and extended, according to angiography atherosclerosis of the coronaries and unfavourable course of disease were associated with hyperlipoproteinemia type II.